← Leaderboards
Charles Drescher
Fred Hutchinson Cancer Research Center
$9,013,816
Attributed
$23,247,614
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,299,768 · 7
By mechanism
UG1$13,340,451 · 1
P50$7,687,329 · 5
U01$5,271,988 · 1
Top collaborators
- Paul D Lampe7 shared
- Christopher I Li7 shared
- Alison K Conlin5 shared
- Sanjiv S Gambhir5 shared
- Robert C Gentleman5 shared
- Muneesh Tewari5 shared
- Dan Sayam Zuckerman3 shared
- Nicole D. Urban2 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Christopher I Li$36,171,442
- Nicole D. Urban$6,041,880
- M Alanna Ruddell$4,483,997
- David G Maloney$3,575,748
- Carlo C Maley$12,698,032
Others in their field
Top investigators on “Malignant Neoplasm Of Ovary”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Weiping Zou · University Of Michigan At Ann Arbor$24,295,958
- Robert C Bast · University Of Texas Md Anderson Can Ctr$22,987,143
Research focus
Malignant Neoplasm Of OvaryWomanMalignant NeoplasmsBloodFundingSuccessTumorAnticancer ResearchCollaborationsResearch StudyResearch PersonnelBaseImageScreening For Ovarian CancerProgramsClinical ResearchSiteEnrollmentClinical TrialsCommunitiesScreeningOperative Surgical ProceduresResourcesSampling
Grant awards (41)
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site$2,706,333
UG1 · FY2025 · CA · contact PI
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site$2,632,282
UG1 · FY2024 · CA · contact PI
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site$2,544,202
UG1 · FY2023 · CA · contact PI
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site$2,579,213
UG1 · FY2022 · CA · contact PI
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site$2,878,421
UG1 · FY2021 · CA · contact PI
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$418,953
U01 · FY2021 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$836,410
U01 · FY2020 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$166,534
U01 · FY2020 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$779,890
U01 · FY2019 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$1,085,901
U01 · FY2018 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$972,870
U01 · FY2017 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center$1,011,430
U01 · FY2016 · CA
Pacific Ovarian Cancer Research Consortium$901,655
P50 · FY2015 · CA · contact PI
Pacific Ovarian Cancer Research Consortium$2,150,499
P50 · FY2013 · CA · contact PI
Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V$254,872
P50 · FY2013 · CA · contact PI
Participant Recruitment, Enrollment and Characterization Core$232,523
P50 · FY2013 · CA · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$191,673
P50 · FY2013 · CA
Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V$273,022
P50 · FY2012 · CA · contact PI
Participant Recruitment, Enrollment and Characterization Core$248,177
P50 · FY2012 · CA · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$210,995
P50 · FY2012 · CA
Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V$257,611
P50 · FY2011 · CA · contact PI
Participant Recruitment, Enrollment and Characterization Core$230,576
P50 · FY2011 · CA · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$200,810
P50 · FY2011 · CA
Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V$279,066
P50 · FY2010 · CA · contact PI
Participant Recruitment, Enrollment and Characterization Core$264,325
P50 · FY2010 · CA · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$219,457
P50 · FY2010 · CA
Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V$282,947
P50 · FY2009 · CA · contact PI
Participant Recruitment, Enrollment and Characterization Core$278,652
P50 · FY2009 · CA · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$228,101
P50 · FY2009 · CA
Core--Clinical$251,362
P50 · FY2008 · CA · contact PI
Core--Clinical$242,381
P50 · FY2007 · CA · contact PI
Core--Clinical$167,619
P50 · FY2006 · CA · contact PI
Core--Clinical$162,872
P50 · FY2005 · CA
Core--Clinical$158,134
P50 · FY2004 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2002 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2001 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2001 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2001 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2001 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2000 · CA
CORE--CLINICAL FACILITY$0
P50 · FY2000 · CA